Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
VEC-H4225 | Human | Human VEGF-C / Flt4-L Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
Human VEGF-C, His Tag (Cat. No. VEC-H4225) captured on CM5 Chip via anti-His antibody can bind Human VEGF R3, Fc Tag (Cat. No. FL4-H5251) with an affinity constant of 41.1 pM as determined in SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
OPT-302 | OPT-302; VGX-300 | Phase 3 Clinical | Orphan Europe Sarl | Neovascularization, Pathologic; Retinal Diseases; Diabetic macular oedema; Retinal Degeneration; Macular Degeneration | Details |
VEGF-C gene therapy (Herantis Pharma) | LX-1101; Ad-VEGF-C | Phase 2 Clinical | Herantis Pharma | Lymphedema | Details |
This web search service is supported by Google Inc.